Drug Guide
Thiopental Sodium
Classification
Therapeutic: Anesthetic, Sedative-Hypnotic
Pharmacological: Barbiturate
FDA Approved Indications
- Induction of anesthesia for surgeries and procedures
Mechanism of Action
Thiopental Sodium enhances GABA-A receptor activity, increasing chloride ion influx, leading to hyperpolarization of neuronal membranes and depressant effects on the Central Nervous System, resulting in anesthesia.
Dosage and Administration
Adult: 2.5-5 mg/kg IV, titrated to desired effect
Pediatric: Not typically used in children due to safety concerns
Geriatric: Start at lower end of dosing range, monitor closely for respiratory and cardiovascular depression
Renal Impairment: Use with caution; dose adjustment may be necessary
Hepatic Impairment: Use cautiously; metabolism may be prolonged
Pharmacokinetics
Absorption: Administered IV, rapid onset
Distribution: Wide, crosses blood-brain barrier and placental barrier
Metabolism: Hepatic biotransformation
Excretion: Renal, primarily as metabolites
Half Life: Approximately 3-8 hours, but effects are brief due to redistribution
Contraindications
- Hypersensitivity to barbiturates
- Porphyria
Precautions
- Cardiovascular disease, respiratory impairment, history of drug dependence, pregnancy (category D), and caution in elderly
Adverse Reactions - Common
- Hypotension (Occasional)
- Respiratory depression (Common)
- Nausea and vomiting (Common)
Adverse Reactions - Serious
- Cardiac arrest (Rare)
- Cytopenias (Rare)
- Allergic reactions (Rare)
Drug-Drug Interactions
- Other CNS depressants, including alcohol, opioids, benzodiazepines
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor cardiovascular and respiratory status closely during and after administration
Diagnoses:
- Risk of decreased cardiac output
- Risk of respiratory depression
Implementation: Ensure resuscitation equipment is available; administer slowly IV; monitor vital signs continuously
Evaluation: Observe for adequate anesthesia depth and recovery status
Patient/Family Teaching
- Inform about possible respiratory and cardiovascular effects
- Advise not to operate machinery or drive for at least 24 hours after use
- Report any signs of allergic reactions or adverse effects
Special Considerations
Black Box Warnings:
- Potential for respiratory and cardiovascular depression, risk of overdose
Genetic Factors: Porphyria may be exacerbated
Lab Test Interference: May alter liver function tests temporarily
Overdose Management
Signs/Symptoms: Deep coma, respiratory depression, hypotension, hypothermia, cardiac arrest
Treatment: Supportive care, maintain airway and breathing, administer vasopressors if needed, activated charcoal if ingestion recent, consider hemoperfusion in severe cases
Storage and Handling
Storage: Store at room temperature, protected from light and moisture
Stability: Stable until expiration date when stored properly